Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triphenylalkene derivatives and their use as selective estrogen receptor modulators

Triphenylalkene derivatives and their use as selective estrogen receptor modulators

US Patent 6576645 · Granted Jun 10, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medicine for Covid-19 and treatment2023
Medicine for Covid-19 and treatment2022
Medicine for Covid-19 and treatment2021
Prodrugs of 17β-HSD1-inhibitors2020
Methods for the treatment of erectile dysfunction using fispemifene2019
Prodrugs of 17.BETA.-HSD1-inhibitors2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydr2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydr2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-h2017
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-h2017
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as2017
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as2017